Redox modulation of NF-κB nuclear translocation and DNA binding in metastatic melanoma. The role of endogenous and γ-glutamyl transferase-dependent oxidative stress

Tumori

Volumn 89, Issue 4, 2003, Pages 426-433

  Dominici, Silvia ^c   Visvikis, Athanase ^b   Pieri, Lisa ^a   Paolicchi, Aldo ^a   Valentini, Marta A ^c   Comporti, Mario ^c   Pompella, Alfonso ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITÉ DE LORRAINE   (France)

^c NONE

Author keywords

Gamma glutamyltransferase; Hydrogen peroxide; Melanoma; NF B; Thiols

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN;

APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0142041923     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900416     Document Type: Article

References (55)

1. Takeshita H, Yoshizaki T, Miller WE, Sato H, Furukawa M, Pagano S, Raab-Traub N: Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J Virol, 73: 5548-5555, 1999.
2. Reuning U, Wilhelm O, Nishiguchi T, Guerrini L, Blasi F, Graeff H, Schmitt M: Inhibition of NF-κB-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1. Nucl Acids Res, 23: 3887-3893, 1995.
3. Dong G, Chen Z, Kato T, Van Waes C: The host environment promotes the constitutive activation of nuclear factor-kappa B and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. Cancer Res, 59: 3495-3504, 1999.
4. Bours V, Dejardin E, Goujon-Letawe F, Merville M-P, Castronovo V: The NF-κB transcription factor and cancer: high expression of NF-κB- and I-κB-related proteins in tumor cell lines. Biochem Pharmacol, 47: 145-149, 1994.
5. Pervaiz S, Ravmalingam JK, Hirpara JL, Clement MV: Superoxide anion inhibits drug-induced tumor cell death. FEBS Lett, 459: 343-348, 1999.
6. Yang CR, Wilson-Van Patten C, Planchon SM, Wuerzberger-Davis SM, Davis TW, Cuthill S, Miyamoto S, Boothman DA: Coordinate modulation of Sp1, NF-kappa B, and p53 in confluent human malignant melanoma cells after ionizing radiation. FASEB J, 14: 379-390, 2000.
7. Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, Rosen CA, Narayanan R: Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci USA, 90: 9901-9905, 1993.
8. Patel PS, Varney ML, Dave BJ, Singh RK: Regulation of constitutive and induced NF-kappaB activation in malignant melanoma cells by capsaicin modulates interleukin-8 production and cell proliferation. J Interferon Cytokine Res, 22: 427-435, 2002.
9. Meyskens FL Jr, Buckmeier JA, Tohidian NB: Constitutive activation of NF-kappaB in human melanoma cells and the effect of oxidative stress. Clin Cancer Res, 5: 1197-1202, 1999.
10. Yang J, Richmond A: Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. Cancer Res, 61: 4901-4909, 2001.
11. Bakker TR, Reed D, Renno T, Jongeneel CV: Efficient adenoviral transfer of Nf-κB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis. Int J Cancer, 80: 320-323, 1999.
12. Franco AV, Zhang XD, Van Berkel E, Sanders JE, Zhang XY, Thomas WD, Nguyen T, Hersey P: The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells. J Immunol, 166: 5337-5345, 2001.
13. Shattuck-Brandt RL, Richmond A: Enhanced degradation of I-κB alpha contributes to endogenous activation of NF-κB in Hs294T melanoma cells. Cancer Res, 57: 3032-3039, 1997.
14. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J, 10: 2247-2258, 1991.
15. Flohé L, Brigelius-Flohé R, Saliou C, Traber MG, Packer L: Redox regulation of NF-kappa B activation. Free Rad Biol Med, 22: 1115-1126, 1997.
16. Piette J, Piret B, Bonizzi G, Schoonbroodt S, Merville MP, Legrand-Poels S, Bours V: Multiple redox regulation in NF-kappaB transcription factor activation. Biol Chem, 378: 1237-1245, 1997.
17. Toledano MB, Leonard WJ: Modulation of transcription factor NF-kappaB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA, 88: 4328-4332, 1991.
18. Kretz-Remy C, Mehlen P, Mirault M-E, Arrigo A-P: Inhibition of IκB-a phosphorylation and degradation and subsequent NF-κB activation by glutathione peroxidase overexpression. J Cell Biol 133: 1083-1093, 1994.
19. Brar SS, Kennedy TP, Whorton AR, Sturrock AB, Huecksteadt TP, Ghio AJ, Hoidal JR: Reactive oxygen species from NAD(P)H: quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells. Am J Physiol Cell Physiol, 280: C659-676, 2001.
20. 2 production, cell surface protein thiol oxidation and NF-κB activation status. J Cell Sci, 113: 2671-2678, 2000.
21. Meyskens FL Jr, McNulty SE, Buckmeier JA, Tohidian NB, Spillane TJ, Kahlon RS, Gonzalez RI: Aberrant redox-regulation in human metastatic melanoma cells compared to normal melanocytes. Free Rad Biol Med, 31: 799-808, 2001.
22. Tate TM, Meister A: γ-glutamyl transpeptidase from kidney. Meth Enzymol, 113: 400-419, 1985.
23. Lu SC, Sun WM, Yi J, Ookhtens M, Sze G, Kaplowitz N: Role of two recently cloned rat liver GSH transporters in the ubiquitous transport of GSH in mammalian cells. J Clin Invest, 97: 1488-1496, 1996.
24. Stark A-A, Zeiger E, Pagano DA: Glutathione metabolism by γ-glutamyl transpeptidase leads to lipid peroxidation: characterization of the system and relevance to hepatocarcinogenesis. Carcinogenesis, 14: 183-189, 1993.
25. Pompella A, Paolicchi A, Dominici S, Comporti M, Tongiani R: Selective colocalization of lipid peroxidation and protein thiol loss in chemically induced hepatic preneoplastic lesions: the role of γ-glutamyl transpeptidase activity. Histochem Cell Biol, 106: 275-282, 1996.
26. Paolicchi A, Tongiani R, Tonarelli P, Comporti M, Pompella A: Gamma-glutamyl transpeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells. Free Rad Biol Med, 22: 853-860, 1997.
27. 2 production and S-thiolation. Free Rad Biol Med, 27: 623-635, 1999.
28. Del Bello B, Paolicchi A, Comporti M, Pompella A, Maellaro E: Hydrogen peroxide produced during gamma-glutamyltranspeptidase activity is involved in prevention of apoptosis and maintenance of proliferation in U937 cells. FASEB J, 13: 69-79, 1999.
29. Hanigan MH, Frierson HF Jr, Brown JE, Lovell MA, Taylor PT: Human ovarian tumors express γ-glutamyl transpeptidase. Cancer Res, 54: 286-290, 1994.
30. Murata J, Ricciardi-Castagnoli P, Dessous L'Eglise Mange P, Martin F, Juillerat-Jeanneret L: Microglial cells induce cytotoxic effects toward colon carcinoma cells: measurement of tumor cytotoxicity with a gamma-glutamyl transpeptidase assay. Int J Cancer, 70: 169-174, 1997.
31. Blair SL, Heerdt P, Sachar S, Abolhoda A, Hochwald S, Cheng H, Burt M: Glutathione metabolism in patients with non-small cell lung cancers. Cancer Res, 57: 152-155, 1997.
32. Tsutsumi M, Sakamuro D, Takada A, Zang SC, Furukawa T, Taniguchi N: Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma. Hepatology, 23: 1093-1097, 1996.
33. Täger M, Ittenson A, Franke A, Frey A, Gassen HG, Ansörge S: γ-Glutamyl transpeptidase-cellular expression in populations of normal human mononuclear cells and patients suffering from leukemias. Ann Hematol, 70: 237-242, 1995.
34. Supino R, Mapelli E, Sanfilippo O, Silvestro L: Biological and enzymatic features of human melanoma cell clones with different invasive potential. Melanoma Res, 2: 377-384, 1992.
35. Huseby NE, Strömme JH: Practical points regarding routine determination of gamma-glutamyl transferase in serum with a kinetic method at 37 °C. Scand J Clin Lab Invest, 34: 357-361, 1974.
36. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res, 19: 2499-2504, 1991.
37. 2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J Immunol Methods, 202: 133-141, 1997.
38. Grisk O, Küster U, Ansörge S: The activity of gamma-glutamyl transpeptidase (γ-GT) in populations of mononuclear cells from human peripheral blood. Biol Chem Hoppe-Seyler, 374: 287-290, 1993.
39. Perego P, Paolicchi A, Tongiani R, Pompella A, Tonarelli P, Carenini N, Romanelli S, Zunino F: The cell-specific antiproliferative effect of reduced glutathione is mediated by gamma-glutamyl transpeptidase-dependent extracellular prooxidant reactions. Int J Cancer, 71: 246-250, 1997.
40. Daubeuf S, Leroy P, Paolicchi A, Pompella A, Wellman M, Galteau MM, Visvikis A: Enhanced resistance of HeLa cells to cisplatin by overexpression of gamma-glutamyltransferase. Biochem Pharmacol, 64: 207-216, 2002.
41. Paolicchi A, Dominici S, Pieri L, Maellaro E, Pompella A: Glutathione catabolism as a signalling mechanism. Biochem Pharmacol, 64: 1029-1037, 2002.
42. Accaoui M-J, Enoiu M, Mergny M, Masson C, Dominici S, Wellman M, Visvikis A: Gamma-glutamyltranspeptidase dependent glutathione catabolism results in activation of NF-κB. Biochem Biophys Res Comm, 276: 1062-1067, 2000.
43. Bowie A, O'Neill LAJ: Oxidative stress and nuclear factor-κB activation. Biochem Pharmacol, 59: 13-23, 2000.
44. Meyer M, Pahl HL, Baeuerle PA: Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem Biol Interact, 91: 91-100, 1994.
45. Anderson MT, Staal FJT, Gitler C, Herzenberg LA, Herzenberg LA: Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc Natl Acad Sci USA, 91: 11527-11531, 1994.
46. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner BM, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF: Tyrosine phosphorylation of IκB activates NF-κB without proteolytic degradation of IκB-a. Cell, 86: 787-798, 1996.
47. Schoonbroodt S, Piette J: Oxidative stress interference with the nuclear factor κB activation pathways. Biochem Pharmacol, 60: 1075-1083, 2000.
48. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT: Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res, 20: 3821-3830, 1992.
49. Meyskens FL Jr, Chau HV, Tohidian N, Buckmeier J: Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress. Pigment Cell Res, 3: 184-189, 1997.
50. Picardo M, Grammatico P, Roccella F, Roccella M, Grandinetti M, Del Porto G, Passi S: Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J Invest Dermatol, 107: 322-326, 1996.
51. Oberlay TD, Oberley LW: Antioxidant enzyme levels in cancer. Histol Histopathol, 12: 525-535, 1997.
52. Paolicchi A, Lorenzini E, Perego P, Supino R, Zunino F, Comporti M, Pompella A: Extra-cellular thiol metabolism in clones of human metastatic melanoma with different gamma-glutamyl transpeptidase expression: implications for cell response to platinum-based drugs. Int J Cancer, 97: 740-745, 2002.
53. Del Bello B, Valentini MA, Zunino F, Comporti M, Maellaro E: Cleavage of Bcl-2 in oxidant- and cisplatin-induced apoptosis of human melanoma cells. Oncogene, 20: 4591-4595, 2001.
54. Voehringer DW, McConkey DJ, McDonnell TJ, Brisbay S, Meyn RE: Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc Natl Acad Sci USA, 95: 2956-2960, 1998.
55. Lahdenpohja N, Savinainen K, Hurme M: Pre-exposure to oxidative stress decreases the nuclear factor-κB-dependent transcription in T lymphocytes. J Immunol, 160: 1354-1358, 1998.